Bär & Karrer has advised the Hero Group on the successful sale of its production facility in Lenzburg to Ricola, advised by Pestalozzi, which is taking over part of the existing production infrastructure as well as offices and a staff restaurant.The buyer aims to expand its production capacity to satisfy the high global demand for […]
Baker McKenzie Switzerland advised B+G Schweiz (a gardening and landscaping company in Switzerland), backed by Swiss investors Patrimonium Private Equity and EGS Beteiligungen, on the acquisition of Garten Holenstein. Following the acquisition, B+
Altenburger advised AMS Group (Inwood Hotels) in the acquisition of the Five Seas Hotel located in Cannes, France, from Donata Bertarelli. The transaction consisted of the acquisition of all shares of Five Seas (Suisse) SA,
Advestra advised European private equity investor Bregal Unternehmerkapital (“Bregal”), together with Paul Hastings in Germany, on the acquisition of Communardo Group (“Communardo”) from, inter alia, Prom12 Capital Fund I, advised by Loyens Loeff. The acquisition
Bär & Karrer advised Circet Group, a provider of telecom inftrastructure services in Europe, on the acquisition of Isen Tiefbau from its founders. Isen Tiefbau Group will serve as a strategic platform for Circet
Wasserman, a global sports, music and entertainment company, has acquired International Football Management (IFM) – advised by Walder Wyss – in a deal announced today by Wasserman vice president, international operations, global football, Lee Charnley. As part
Kellerhals Carrard advised Thömus – from Oberried, near Bern – which is taking over 12 ‘Bike World’ branches and their employees from Migros. The locations will be redesigned and will reopen under the name ‘Thömus Bike
Walder Wyss advised the shareholders of Saiba Animal Health in the sale of all shares to the biopharmaceutical company Boehringer Ingelheim. With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&
Pestalozzi advised RUAG International in the sale of the lithography division to Zeiss SMT. The agreement includes all employees and assets associated with the two production sites in Zurich (Switzerland) and Coswig (Germany). The acquisition
Vischer advised Haya Therapeutics, a Swiss biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics, which announced a multi-year agreement with Eli Lilly and Company to apply Haya’s advanced RNA-guided regulatory genome platform to
